Massachusetts General Hospital Comprehensive Hemophilia and Thrombosis Treatment Center is a clinical research site located in Boston, Massachusetts, United States 02114.
Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.
Massachusetts General Hospital Comprehensive Hemophilia and Thrombosis Treatment Center has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Hemophilia A With Inhibitor, Hemophilia B With Inhibitor, Hematologic Disorder.
Sponsors: American Thrombosis and Hemostasis Network.
Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Massachusetts General Hospital Comprehensive Hemophilia and Thrombosis Treatment Center has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Massachusetts General Hospital Comprehensive Hemophilia and Thrombosis Treatment Center has 3 clinical trials on record, with 2 currently active. Their work covers Hemophilia A With Inhibitor, Hemophilia B With Inhibitor, Hematologic Disorder.
Massachusetts General Hospital Comprehensive Hemophilia and Thrombosis Treatment Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.